China News
-
Eisai's new Anti-insomnia drug Dayvigo approved in Hong Kong
China | News | 4 Comment | 08 Jul, 2020
Eisai Co., Ltd. announced on 7 July 2020 that the new drug application for approval of its in-house-discovered and ...Read more
-
Evive Biotech meets promising results at Global Ph III trial for neutropenia treatment
China | News | 0 Comment | 08 Jul, 2020
Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivot...Read more
-
Polaris Biology pushes next-gen T cell detection reagents
China | News | 0 Comment | 07 Jul, 2020
China based startup Polaris Biology and Denmark based Tetramer Shop have announce a strategic partnership to c...Read more
-
CF PharmTech pushes commercialization of inhalation products
China | News | 0 Comment | 07 Jul, 2020
China based CF PharmTech, Inc. announced that it has raised US $50M in Series F financing following its US $90...Read more
-
China works on traditional medicine formula against COVID-19
China | News | 0 Comment | 02 Jul, 2020
The research team of Handian Pharmaceutical Medical Center and Handian Traditional Chinese Medicine Hospital has devoted...Read more
-
Novel technology Generates Biocatalysts for Biodiesel Production
China | News | 0 Comment | 25 Jun, 2020
A research team from the School of Life Sciences at The Chinese University of Hong Kong (CUHK) has developed a novel met...Read more
-
Evive Biotech unveiled as the new corporate brand for Generon Biomed
China | News | 0 Comment | 24 Jun, 2020
Generon BioMed Inc, an innovative biotech company developing novel biological therapeutics, announced on 24 June 2020 th...Read more
-
World's 1st inactivated COVID-19 vaccine produces Abs
China | News | 0 Comment | 24 Jun, 2020
The Phase I/II clinical trials of the world's first inactivated COVID-19 vaccine, developed by Wuhan Institute of Biolog...Read more
-
Merck’s KEYTRUDA (pembrolizumab) approved in China for ESCC Tumors
China | News | 0 Comment | 23 Jun, 2020
Merck, known as MSD outside the United States and Canada, on 22 June 2020 announced that KEYTRUDA, Merck&rsquo...Read more
-
Cardiovascular disease (CVD) impact on Asia-Pacific markets
China | Analysis | 2 Comment | 23 Jun, 2020
HONG KONG Prevalence CVD, including heart attack and stroke, is the third leading cause of death in Hong Kong (aft...Read more
-
EIU launches APAC Economist Intelligence Unit report for heart ailments
China | News | 0 Comment | 23 Jun, 2020
The Cost of Inaction: Secondary Prevention of Cardiovascular Disease in Asia-Pacific Rehabilitation ...Read more
-
WuXi Biologics to open clinical manufacturing facility in US
China | News | 0 Comment | 23 Jun, 2020
China based WuXi Biologics, a global company with leading open-access biologics technology platforms, announced that it ...Read more
-
Alphamab, Sanofi collaborate for breast cancer research
China | News | 0 Comment | 18 Jun, 2020
China based Alphamab Oncology, a clinical stage biopharmaceutical company focusing on innovative biologics medicine...Read more
-
PolyU to advance diagnosis of COVID-19 pneumonia
China | News | 0 Comment | 17 Jun, 2020
In the face of a surge in cases, rapid diagnosis and identification of high-risk patients for early intervention is cruc...Read more
-
Sinovac to initiate Ph 3 trial of COVID-19 vaccine
China | News | 0 Comment | 16 Jun, 2020
China-based Sinovac Biotech Ltd. inked a clinical development collaboration agreement with a Brazilian producer of immun...Read more
-
Sichuan & Oxford University set up joint cancer research centre
China | News | 0 Comment | 15 Jun, 2020
The University of Oxford and China's Sichuan University have jointly launched a center to bolst...Read more
-
AXA Asia launches resources for COVID-19 management
China | News | 0 Comment | 12 Jun, 2020
AXA, serving customers across seven fast-growing markets including Hong Kong, mainland China, Japan, South Korea, the Ph...Read more
-
Alphamab Oncology, Institut Pasteur Shanghai to co-develop COVID-19 neutralizing Ab
China | News | 0 Comment | 11 Jun, 2020
Alphamab Oncology has announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd., a wholly-owned subsidiary of the Com...Read more
